OBJECTIVE: The primary aim of this study was to determine if there is a change in the quality of life in pediatric patients with unremitting functional constipation and/or encopresis after undergoing a MACE procedure. METHODS: Patients, ages 5 to 18 years with unremitting constipation and a normal evaluation, including anorectal manometry and colonic manometry, who opted to undergo a MACE procedure were contacted to participate in the study. Patients with congenital anorectal malformations as well as spinal cord disorders were excluded from the study. The patient's parent/guardian completed the PedsQL(TM) Generic Core Scales QOL survey prior to the operation, 6 months, and 12 months after the procedure. RESULTS: A total of 15 consecutive patients meeting protocol criteria were recruited within a period of 20 months. The mean age at the MACE procedure was 9.8 years (range 7.0-11.1). 5 patients were female. The mean QOL score pre-MACE was 64.1. At 6 months post-MACE the mean overall QOL score was 90.2, and it was 92.0 at 12 months. All 15 patients at the 6 month follow up had significant improvement in their QOL (p=1.9 × 10(-7)) and all subcategories of QOL were significantly improved as well. CONCLUSIONS: A MACE procedure is of benefit to otherwise normal pediatric patients who have unremitting functional constipation with failure of medical treatment. Our patients had a significant improvement in all QOL categories and overall QOL.
OBJECTIVE: The primary aim of this study was to determine if there is a change in the quality of life in pediatric patients with unremitting functional constipation and/or encopresis after undergoing a MACE procedure. METHODS:Patients, ages 5 to 18 years with unremitting constipation and a normal evaluation, including anorectal manometry and colonic manometry, who opted to undergo a MACE procedure were contacted to participate in the study. Patients with congenital anorectal malformations as well as spinal cord disorders were excluded from the study. The patient's parent/guardian completed the PedsQL(TM) Generic Core Scales QOL survey prior to the operation, 6 months, and 12 months after the procedure. RESULTS: A total of 15 consecutive patients meeting protocol criteria were recruited within a period of 20 months. The mean age at the MACE procedure was 9.8 years (range 7.0-11.1). 5 patients were female. The mean QOL score pre-MACE was 64.1. At 6 months post-MACE the mean overall QOL score was 90.2, and it was 92.0 at 12 months. All 15 patients at the 6 month follow up had significant improvement in their QOL (p=1.9 × 10(-7)) and all subcategories of QOL were significantly improved as well. CONCLUSIONS: A MACE procedure is of benefit to otherwise normal pediatric patients who have unremitting functional constipation with failure of medical treatment. Our patients had a significant improvement in all QOL categories and overall QOL.
Authors: João H F Colares; Marionescu Purcaru; Guilherme P F da Silva; Mirna A Frota; Carlos A B da Silva; Antônio A Melo-Filho; Andrea Bischoff; Alberto Peña Journal: Pediatr Surg Int Date: 2016-02-13 Impact factor: 1.827
Authors: Riyad Peeraully; Jason Langley; Nicola Hayes; Kate Storry; Louise Richardson; Demelza Burridge; Bharat More Journal: Pediatr Surg Int Date: 2022-04-08 Impact factor: 1.827
Authors: Jennifer J Freeman; Siddartha Simha; Marcus D Jarboe; Peter F Ehrlich; Daniel H Teitelbaum Journal: Pediatr Surg Int Date: 2014-05-30 Impact factor: 1.827
Authors: R Sturkenboom; A A van der Wilt; S M J van Kuijk; A Ahmad; P T Janssen; L P S Stassen; J Melenhorst; S O Breukink Journal: Int J Colorectal Dis Date: 2018-06-22 Impact factor: 2.571
Authors: Bhalaajee Meenakshi-Sundaram; Caitlin T Coco; James R Furr; Byron P Dubow; Christopher E Aston; Jennifer Lewis; Gennady Slobodov; Bradley P Kropp; Dominic C Frimberger Journal: J Urol Date: 2017-07-18 Impact factor: 7.600
Authors: Jason R Baker; Baha Moshiree; Satish Rao; Leila Neshatian; Linda Nguyen; William D Chey; Richard Saad; Jose M Garza; Shamaila Waseem; Abraham R Khan; John E Pandolfino; C Prakash Gyawali Journal: Am J Gastroenterol Date: 2020-10 Impact factor: 12.045
Authors: Vanesca P A de Arruda; Maria A Bellomo-Brandão; Joaquim M Bustorff-Silva; Elizete Aparecida Lomazi Journal: J Pediatr (Rio J) Date: 2018-10-22 Impact factor: 2.990